Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
A Phase 1 Study With an Expansion Cohort/Randomized Phase 2 Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Lisa Roth, MD
Date: February 21, 2019
Advanced Endoscopic Therapies (AETs): A Retrospective and Prospective Multicenter Registry
Study Status:
Open to Enrollment
Primary Investigator:
Reem Sharaiha, MD
Date: December 6, 2018
TARGET–NASH: A 5-year Longitudinal Observational Study of Patients with Non-Alcoholic Fatty Liver or Non-Alcoholic Steatohepatitis
Study Status:
Open to Enrollment
Primary Investigator:
Robert S. Brown, MD, MPH
Date: November 9, 2018
A Gene-Transfer, Open-Label, Dose-Escalation Study of SPK-8011 [Recombinant Adeno-Associated Viral Vector with B-Domain Deleted Human Factor VIII Gene] in Individuals with Hemophilia A
Study Status:
Open to Enrollment
Primary Investigator:
Catherine McGuinn
Date: November 2, 2018
IRONMAN: International Registry for Men with Advanced Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Scott Tagawa, MD, MS
Date: September 25, 2018
Fecal Microbiota Transplantation National Registry
Study Status:
Open to Enrollment
Primary Investigator:
Carl V. Crawford, Jr., MD
Date: August 24, 2018
(CLONEVO): Cell cycLe inhbitiON to target the EVolution of urOthelial cancer
Study Status:
Open to Enrollment
Primary Investigator:
Bishoy Faltas, M.D.
Date: June 8, 2018
ROMA Trial
Study Status:
Open to Enrollment
Primary Investigator:
Mario Gaudino M.D.
Date: February 14, 2018
Comprehensive Care in Patients with Thalassemia and Severe Congenital Anemias
Study Status:
Open to Enrollment
Primary Investigator:
Sujit Sheth MD
Date: December 5, 2017
Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients With a History of Cancer (SAPPHIRE)
Study Status:
Open to Enrollment
Primary Investigator:
Ellen J. Scherl, M.D.
Date: August 22, 2017